These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1087754)
1. [Study of cellular immunology in malignant and benign monoclonal gammapathies]. Gasparotto G; Semenzato G; Tosato F; Cazzaro G; Amadori G Schweiz Med Wochenschr; 1976 Dec; 106(50):1823-5. PubMed ID: 1087754 [TBL] [Abstract][Full Text] [Related]
2. Peripheral lymphocytes in paraproteinemia. Amadori G; Semenzato G; Tosato F; Cazzaro G; Sarasin P; Gasparotto G Boll Ist Sieroter Milan; 1976; 55(5):426-30. PubMed ID: 1016593 [TBL] [Abstract][Full Text] [Related]
3. [Determination of lymphocyte subpopulations in multiple myeloma and monoclonal gammopathies of undetermined significance]. Luraschi A; Fedeli P; Rossi M; Montanara S; Perlasca S; Cozzi S Minerva Med; 1986 Jun; 77(26):1235-41. PubMed ID: 3088491 [TBL] [Abstract][Full Text] [Related]
4. B and T lymphocytic populations and subpopulations and natural killer cells (NK) in blood of patients with myeloma and with monoclonal gammopathy of undetermined significance (MGUS). Büchi G; Girotto M; Termine G; Gario S; Grosso E; Autino R; Zappalà C Pathologica; 1985; 77(1050):385-93. PubMed ID: 3879633 [No Abstract] [Full Text] [Related]
5. Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma. Perri RT; Oken MM; Kay NE J Lab Clin Med; 1982 Apr; 99(4):512-9. PubMed ID: 6460827 [TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load. Bergenbrant S; Osterborg A; Holm G; Mellstedt H; Lefvert AK Br J Haematol; 1991 May; 78(1):66-70. PubMed ID: 2043484 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte response to phytohemagglutinin (PHA) in in vitro culture and quantitative and qualitative changes in serum immunoglobulins in patients with plasma-cell myeloma. Traczyk Z; Cieśluk S; Snigurowicz J Arch Immunol Ther Exp (Warsz); 1975; 23(1):105-11. PubMed ID: 803827 [No Abstract] [Full Text] [Related]
9. [Immunopathology of paraproteinemic hemoblastoses]. Huber H; Gattringer C; Peer L Acta Med Austriaca; 1982; 9(4):135-8. PubMed ID: 6982580 [TBL] [Abstract][Full Text] [Related]
10. Circulating B and T lymphocytes in myeloma and benign monoclonal gammopathies. Büchi G; Termine G; Girotto M; Gario S; Autino R Haematologica; 1983; 68(2):179-89. PubMed ID: 6407913 [No Abstract] [Full Text] [Related]
11. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin. Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376 [TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system]. Westerhausen M Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157 [TBL] [Abstract][Full Text] [Related]
13. Antigen stimulated IgM secretion by circulating B lymphocytes in patients with benign and malignant IgG gammopathy. Relationship to stage of disease. Pollack S; Katz R; Tatarsky I; Carter A Clin Exp Immunol; 1989 Jan; 75(1):12-7. PubMed ID: 2522837 [TBL] [Abstract][Full Text] [Related]
14. [Changes in the in vitro antibody formation in B lymphoproliferative diseases]. Olgiati A; Bernasconi P; Salomone A; Mancini M; De Nicola P; Gibelli A Minerva Med; 1985 Sep; 76(34-35):1557-62. PubMed ID: 3875811 [TBL] [Abstract][Full Text] [Related]
15. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)]. Knopf B; Wätzig V; Knöll B Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289 [TBL] [Abstract][Full Text] [Related]
16. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes. Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Cassel A; Leibovitz N; Hornstein L; Quitt M; Aghai E Exp Hematol; 1990 Dec; 18(11):1171-3. PubMed ID: 2226677 [TBL] [Abstract][Full Text] [Related]
18. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen. Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450 [TBL] [Abstract][Full Text] [Related]
19. Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens. Peest D; Gasch S; Thiele C; Bartels B; Brunkhorst U; Dallmann I; Hoffmann M; Schedel I; Deicher H Clin Exp Immunol; 1986 Jul; 65(1):120-7. PubMed ID: 3098470 [TBL] [Abstract][Full Text] [Related]